hyperthyroidism
HYPERTHYROIDISM
Hyperthyroidism is the overactivity of the thyroid gland resulting in excessive production of thyroid hormones.
Symptoms are of gradual onset.
Earliest signs may be emotional lability and motor hyperactivity; decline in school performance may also be noted.
Causes are autoimmune (Grave's disease), inappropriate stimulation by trophic factors, passive release of preformed thyroid hormone stores in response to infections, trauma, or other offensive factors inside the body, and extra-thyroidal sources.

Hyperthyroidism Management

Follow Up

  • Thyroid function monitoring (free T4, total T3, TSH) is advised for the following:
    • Two to 6 weeks after initiation of antithyroid drug therapy, again at 4-6 weeks, then every 2-3 months once dose has been stabilized
    • Lifelong monitoring for all patients previously prescribed with antithyroid drug therapy
    • Monthly monitoring after completion of radioactive iodine therapy
  • Doses of antithyroid medications should be discontinued or titrated after 1-2 years of continuous treatment, to assess for disease remission
  • Lifelong monitoring of thyroid function is advised for all patients previously prescribed w/ antithyroid drug therapy
  • Instruct the parents/guardians of patients to immediately report signs of liver dysfunction (jaundice, pruritus, rash, anorexia, right upper quadrant pain, light-colored stool, dark urine)
  • Consider radioactive iodine therapy or surgery in patients on antithyroid therapy (Methimazole) for >1-2 years
  • Relapse after discontinuation of therapy occurs in 3-47% of pediatric population
    • Studies show that relapse usually occurs within 1 year after treatment discontinuation
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
4 days ago
Daily intake of cow’s milk formula in early life helps prevent the development of cow’s milk allergy later on without competing with breastfeeding, a recent study has found.